| PRODUKT |
CATALOG # |
DESCRIPTION |
AMOUNT |
|
sc-203769 |
2-Guanidinoethylmercaptosuccinic Acid, also knowns as GEMSA, is a potent inhibitor of enkephalin convertase, known as a carboxypeptidase B-like processing enzyme. |
5 mg |
|
sc-3502 |
A potent, irreversible inhibitor of serine proteases. |
10 mg |
|
sc-203320 |
An electrophile used for covalent modification of cysteine, methionine, and histidine protein residues. |
25 g |
|
sc-203802 |
Aspartyl protease inhibitor that acts as an effective inhibitor of HIV-1 proteinase (Ki = 20 nM at pH 4.7) and HIV-2 proteinase (Ki = 5 nM at pH 4.7).
|
1 mg |
|
sc-202041 |
A broad spectrum, water soluble, irreversible serine protease inhibitor. Serves as a stable, nontoxic alternative to PMSF (sc-3597) and DFP. |
50 mg/100 mg |
|
sc-291906 |
A reversible inhibitor of Ser and Cys proteases with an activity spectrum comparable to leupeptin. H-1765 inhibited transformation of NIH3T3 cells after transfection with an activated H-ras oncogene. Has been employed for evaluating the role of proteases in the process of malignant transformation of BALB/c 3T3 cells. |
5 mg/25 mg |
|
sc-291907 |
A reversible protease inhibitor produced by actinomycetes. Inhibits cathepsin A and B as well as papain, and trypsin-like serine proteases. Acts by forming a hemiacetal adduct between the aldehyde group of the inhibitor and the active proteinase. Effective at concentrations range from 1 to 100 µM. |
5 mg/25 mg |
|
sc-3595 |
Reversible inhibitor of esterase and serine protease activity such as trypsin, chymotrypsin, kallikrein, plasmin, urokinase, and leukocyte protease. |
10 mg/100 mg |
|
sc-201309 |
Apstatin is a selective inhibitor of Aminopeptidase P (APP), shown to increase Bradykinin-promoted cardioprotection by blocking APP degredation of Bradykinin. |
1 mg |
|
sc-201293 |
An Aminopeptidase B inhibitor reported to also inhibit enkephalin-degrading enzymes in the small intestine. Can decrease production of collagen in cardiac fibroblast cells. |
5 mg/25 mg |
|
sc-202959 |
A bacterial product that acts as a specific Aminopeptidase B inhibitor, a metalloprotease. |
1 mg/5 mg |
|
sc-361112 |
AZ 10417808 is a selective non-peptide caspase-3 and DEVDase activity inhibitor. |
10 mg/50 mg |
|
sc-202967 |
Shown to be an irreversible cysteine protease inhibitor that contains aziridine-2,3-dicarboxylic acid as a reactive agent. Also been reported to be active against plasmodial and lysosomal cysteine proteases. |
2 mg |
|
sc-202973 |
Inhibitor of serine protease enzymes. |
5 g/25 g |
|
sc-202975 |
A potent aminopeptidase inhibitor that can bind to the surface of cells, directly stimulate lymphocytes and indirectly act on monocytes. |
10 mg |
|
sc-200564 |
An inhibitor of aminopeptidases and leukotriene A4 hydrolase. |
5 mg/25 mg |
|
sc-361130 |
Butabindide oxalate is a selective and potent inhibitor of tripeptidyl peptidase II. |
10 mg/50 mg |
|
sc-29119 |
Inhibitor of Ca2+-dependent neutral cysteine proteases Calpain I and Calpain II, Papain and Cathespin B and L. Weak inhibitor of Cathespin H and α-chymotrypsin. Does not inhibit trypsin. |
25 mg |
|
sc-203867 |
Reported to be a protease and Trypsin inhibitor. Also shown to suppress spinal Fos expression in the rat and have direct regulatory effects on ductular cells of the dog pancreas. |
10 mg/50 mg |
|
sc-202541 |
A bioactive peptide protease inhibitior containing chymostatin A as a major form. Specifically inhibits chymotrypsin, papain, cathepsin G and most cysteine proteases. |
5 mg/10 mg |
|
sc-201312 |
A specific inhibitor of DPEP1, leukotriene D4 hydrolase and bacterial metallo-beta-lactamase. Exhibits nephroprotective effects in cyclosporine A-induced nephrotoxicity and is commonly used in conjunction with the antibiotic Imipenem (sc-205350). |
10 mg/50 mg |
|
sc-29131 |
EDTA-free mixture of several protease inhibitors that inhibit cysteine and serine, but not metalloproteases. |
20 tablets |
|
sc-29130 |
Mixture of several protease inhibitors with broad inhibitory specificity. Useful for inhibition of serine, cysteine, and metalloproteases. |
20 tablets |
|
sc-361157 |
CP 471474 has been reported to be a matrix metalloprotease (MMP) inhibitor. |
10 mg/50 mg |
|
sc-203922 |
Serine protease inhibitor. Irreversible inactivator of acetylcholinesterase that can cross the blood-brain barrier. Selectively blocks T cell receptor-triggered programmed cell death in murine T cell hybridoma and in activated peripheral T cells. |
1 g |
|
sc-202146 |
An antifibrinolytic agent which inhibits streptokinase and basic carboxypeptidases, but has been shown to enhance activation of urinary-type and tissue-type plasminogen. |
500 g |
|
sc-201276 |
A broad spectrum cysteine proteinase and calpain activation inhibitor. The compound has been reported to inhibit intracellular cathepsin B, Bax protease activity, and reduce oxidative stress. |
5 mg/25 mg |
|
sc-200826 |
Effective pancreatic lipase inhibitor derived from Streptomyces aburaviensis. Also inhibits hydrolysis of bradykinin and angiotensin (angiotensin I) through serine carboxypeptidase Y-like enzymes. |
1 mg |
|
sc-221575 |
A strong broad range inhibitor of serine proteases. Exhibits picomolar binding constant for the inhibition of chymotrypsin, elastase, Factor Xa, Factor XIIa, kallikrein, and trypsin. Also acts as an effective inhibitor of collagenase. Exhibits biological activity by binding trypsin in the picomolar range. |
100 µg |
|
sc-221584 |
A Serine protease inhibitor that Inhibits porcine pancreatic elastase and thermitase. |
1 mg |
|
sc-201272 |
A protease inhibitor that can inhibit PMSF (sc-3597) degradation of H1 histones and HMG proteins. Has no effect on DNA repair and UV-induced sister chromatid exchanges, and inhibits 2A proteinase. |
5 mg/25 mg |
|
sc-214965 |
A metallo-protease inhibitor with selectivity for aminopeptidases. |
1 mg |
|
sc-361180 |
FR 171113 has been shown to be a protease-activated receptor 1 (PAR1) antagonist. This compound has also displayed the ability to inhibit platelet activity in vitro as well as thrombin TRAP-6-induced platelet aggregation. |
10 mg/50 mg |
|
sc-200377 |
A complex natural product antibiotic, inhibits methionine aminopeptidase type II (MetAP-2) and suppresses angiogenesis. |
1 mg/5 mg |
|
sc-215066 |
Serine protease inhibitor. |
5 mg |
|
sc-363651 |
|
10 mg |
|
sc-204014 |
A reagent shown to be used to modify cysteine residues in proteins to ultimately inhibit cysteine proteases. |
25 g |
|
sc-295238 |
This product inhibits protease, and inactivates chymotrypsin but does not inactivate trypsin. It has been shown to irreversibly inhibit chymotrypsin-like serine proteases including ficin, bromelain, and papain. It has also been shown to inhibits I kappaB alpha-protease. Inhibition of I kappaB alpha-protease blocks the LPS- or cytokine-induced activation of nuclear factor kappaB (NF-kappaB), which then blocks iNOS induction and COX-2 transcription. It is reported to block apoptosis cell lines through the inhibition of the processing of caspases in some cell lines and to some stimuli. It can also be used in histone isolation. |
100 mg/250 mg |
|
sc-295358 |
A reversible compeptitive protease inhibitor, which has been shown to inhibit cathepsins B, H, L, and S, calpain and trypsin. |
5 mg/25 mg |
|
sc-215242 |
Produced by Actinomycetes and act as calpain, cysteine, and protease inhibitors. Studies show that Leupeptin preserves cardiac nitric oxide synthase 3 (NOS3). |
5 mg/25 mg |
|
sc-215243 |
Inhibitor of serine and cysteine proteases, as well as plasmin, trypsin, papain and cathepsin B. No inhibition found with pepsin, cathepsins A and D, thrombin, or α-chymotrypsin. Effective concentration 10-100 µM |
1 mg/5 mg |
|
sc-202707 |
Protein kinase C (PKC) activator. Second stage tumor promoter whereas phorbol-12-myristate 13-acetate (PMA) is a first stage tumor promoter. May be of use for studying phorbol ester receptor isotypes. Induces interleukin-1α. Coinducer of interferon with phytohemagglutinin. |
1 mg |
|
sc-201307 |
A highly effective tryptase (Ki=95.3 pM) inhibitor that can promote synthesis of interferon-gamma, tumor necrosis factor-alpha, IL-12, and IL-18. |
10 mg/50 mg |
|
sc-222101 |
|
10 mg |
|
sc-204155 |
An irreversible and specific protease inhibitor that blocks intracellular acidification, DNA fragmentation, and 5-Fluoro-2'-deoxyuridine induced cell death. |
5 mg |
|
sc-45036 |
Inhibits the aspartic proteases: cathepsin D, pepsin, and renin. |
5 mg/25 mg |
|
sc-222151 |
|
1 mg/5 mg |
|
sc-3597 |
Inhibits Ser proteases like chymotrypsin, trypsin, and thrombin and most cysteine proteases, like papain. Also inhibits metalloproteases and aspartic proteases. Suitable substitute for DFP (sc-203922). |
1 g/100 g |
|
sc-201283 |
An inhibitor of the metalloprotease NEP and its homologue NEP2, which both belong to a group of type II integral membrane glycoproteins. |
5 mg/25 mg |
|
sc-203215 |
A potent, specific and irreversible inhibitor of glandular and plasma kallikreins. Inhibits rat adrenal kininogenase and inactivates native human hageman factor. |
10 mg |
|
sc-264149 |
Inhibits cysteine and serine proteases. |
25 mg/100 mg |
|
sc-361359 |
Sivelestat sodium salt, with an IC50 of 44 nM, is a selective leukocyte elastase inhibitor. The compound functions, through in vitro observations, by blocking LTB4-induced neutrophil transmigration and NF-κB activation. |
10 mg/50 mg |
|
sc-201287 |
An enkephalinase and metalloproteinase inhibitor that shows antinociceptive activity. Displays antiapoptotic and proliferative protective effects. |
5 mg/25 mg |
|
sc-201296 |
Irreversibly inhibits trypsin-like serine proteases such as granzyme D. Inhibits LPS-induced expression of COX-2 in macrophages and the chymotrypsin- and trypsin-like activity of the proteasome. |
200 mg |
|
sc-201297 |
A potent serine and cysteine protease inhibitor, disables NF-κB activation and subsequently shuts down COX-2 activity. |
1 g |
|
sc-204358 |
Specific, reversible inhibitor of trypsin. Also inhibits human Factor XIIa. May function in host resistance against fungal pathogens in crops. |
1 mg |
|
sc-361392 |
UK 356618 is a selective and potent inhibitor of MMP-3 that shows selectivity over a range of MMPs. |
10 mg |
|
sc-311559 |
A novel cysteine protease inhibitor that specifically and efficiently inhibits processing of the p-Prl signal peptide. |
5 mg |
High quality protease inhibitors are provided as individual inhibitors and as cocktails to effectively protect proteins from a broad range of unwanted protease activity including serine, cysteine, and metelloproteases. One unit of activity is defined as the amount of enzyme that converts 1 µmol of substrate to product in one minute under the given assay conditions. Complete Protease Inhibitor Cocktail Tablet and Complete Protease Inhibitor Cocktail Tablet, EDTA-free are trademarks of Roche Applied Science.
|